Genesis Innovation Group names **Patrick Jamnik** as its new **Chief of Staff**. The medical device development firm collaborates with inventors and early-stage companies to accelerate product commercialization. Jamnik joins to support strategic operations and scaling initiatives.
Capitan Orthopedics secures an oversubscribed Seed funding round, raising a total of **$4.1 million** to date. The company specializes in orthopedic solutions and leverages the capital to advance its technology and market expansion. The round reflects strong investor demand in the medical device sector.
Capitan Orthopedics secures FDA Breakthrough Device Designation for its **SupraSpacer™ implant**, a medical device innovation. The designation accelerates regulatory review for technologies intended to address unmet medical needs. The company now aims to streamline development and bring the implant to market faster, targeting orthopedic conditions requiring advanced spinal solutions.